OrganoClick AB (OSTO:ORGC) Total Equity: kr18.77 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ORGC OrganoClick AB OSTO:ORGC
25 GF Score
Price kr0.42
GF Value kr1.99
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is OrganoClick AB Total Equity?

OrganoClick AB OSTO:ORGC +11.94% 25 Total Equity is kr18.77 Mil as of Mar. 2026. GuruFocus rates OSTO:ORGC with a GF Score™ of 25/100 and a GF Value™ of kr1.99 (Possible Value Trap). The stock has 4 warning signs investors should review.

OrganoClick AB's total equity for the quarter that ended in Mar. 2026 was kr18.77 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

OrganoClick AB Total Equity Historical Data

* Premium members only.

The historical data trend for OrganoClick AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrganoClick AB Total Equity Chart

OrganoClick AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 107.73 67.56 53.41 37.83 20.41

OrganoClick AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.11 28.23 40.20 20.41 18.77
OSTO:ORGC
25GF Score
OrganoClick AB OSTO:ORGC
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrganoClick AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

OrganoClick AB's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=135.218-114.81
=20.41

OrganoClick AB's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=147.686-128.921
=18.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of kr18.77 Mil mean?
OrganoClick AB (OSTO:ORGC) has a Total Equity of kr18.77 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for OrganoClick AB and its competitors.
Is OrganoClick AB's Total Equity too high?
OrganoClick AB's current Total Equity is kr18.77 Mil. Overall, OrganoClick AB has a GF Score™ of 25/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OrganoClick AB's Total Equity compare to LIN and SHW?
OrganoClick AB's Total Equity of kr18.77 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Chemicals company?
A good Total Equity depends on the Chemicals industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for OrganoClick AB and its competitors. OrganoClick AB's current Total Equity is kr18.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrganoClick AB stock overvalued right now?
Based on GuruFocus' analysis, OrganoClick AB (OSTO:ORGC) is currently considered Possible Value Trap. The stock's GF Value™ is kr1.99, compared to a current price of kr0.42 — trading 78.8% below its estimated fair value. The current Total Equity is kr18.77 Mil. OrganoClick AB's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For OrganoClick AB (OSTO:ORGC), the current Total Equity is kr18.77 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrganoClick AB (OSTO:ORGC) Overvalued in 2026?

Based on GuruFocus' analysis, OrganoClick AB stock appears to be undervalued. The current stock price of kr0.42 is trading 78.8% below its estimated GF Value™ of kr1.99. GuruFocus considers OrganoClick AB to be Possible Value Trap.

Key valuation signals for OSTO:ORGC:

  • Total Equity: kr18.77 Mil
  • GF Value™: kr1.99 vs. price of kr0.42 (78.8% below fair value)
  • GF Score™: 25/100 with 4 warning signs

No single metric tells the full story. See the OSTO:ORGC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OrganoClick AB Business Description

Other Exchanges 0CF:Germany
Address Linjalvagen 9, Taby, SWE, SE-187 66
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
25GF Score

Get the complete analysis for OSTO:ORGC

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.42
Price
kr1.99
GF Value